Scott Mendel
Directeur/Membre du Conseil chez AKOYA BIOSCIENCES, INC.
Fortune : 337 237 $ au 30/04/2024
Postes actifs de Scott Mendel
Sociétés | Poste | Début | Fin |
---|---|---|---|
AKOYA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/06/2021 | - |
Independent Dir/Board Member | 11/06/2021 | - | |
QUANTUM-SI INCORPORATED | Directeur/Membre du Conseil | 15/05/2023 | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | 04/01/2022 | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | 06/01/2022 | - |
Historique de carrière de Scott Mendel
Anciens postes connus de Scott Mendel
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACTIVE NETWORK INC | Directeur Financier/CFO | 01/03/2010 | 01/12/2013 |
GE AEROSPACE | Corporate Officer/Principal | 01/03/2003 | 01/03/2010 |
GENMARK DIAGNOSTICS, INC. | Comptroller/Controller/Auditor | 13/05/2014 | 18/02/2019 |
Directeur/Membre du Conseil | 02/05/2020 | 22/04/2021 | |
Directeur Général | 10/02/2020 | - | |
Directeur des opérations | 18/02/2019 | 02/05/2020 | |
Directeur Financier/CFO | 13/05/2014 | 18/02/2019 | |
President | 10/02/2020 | - |
Formation de Scott Mendel
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Director/Board Member | 5 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Technology Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
GE AEROSPACE | Producer Manufacturing |
AKOYA BIOSCIENCES, INC. | Health Technology |
QUANTUM-SI INCORPORATED | Technology Services |
Entreprise privées | 4 |
---|---|
Active Network LLC
Active Network LLC Packaged SoftwareTechnology Services Active Network LLC engages in cloud based activity and participant management solutions. It offers software solutions for race management, recreation management, outdoor management, camp management, church management, ski and attractions, sports management, school management, and swim management. The company was founded by Scott Galen Kyle, Mitchell F. Thrower, David Alberga, and Jim Woodman in 1999 and is headquartered in Dallas, TX. | Technology Services |
GenMark Diagnostics, Inc.
GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Bourse
- Insiders
- Scott Mendel
- Expérience